These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28194636)

  • 1. Evaluation of the Utility of Chimeric Mice with Humanized Livers for the Characterization and Profiling of the Metabolites of a Selective Inhibitor (YM543) of the Sodium-Glucose Cotransporter 2.
    Nakada N
    Pharm Res; 2017 Apr; 34(4):874-886. PubMed ID: 28194636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of metabolites of ASP015K, a novel oral Janus kinase inhibitor, in rats, chimeric mice with humanized liver, and humans.
    Nakada N; Oda K
    Xenobiotica; 2015; 45(9):757-65. PubMed ID: 25869242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine Cyp3a knockout chimeric mice with humanized liver: prediction of the metabolic profile of nefazodone in humans.
    Nakada N; Kawamura A; Kamimura H; Sato K; Kazuki Y; Kakuni M; Ohbuchi M; Kato K; Tateno C; Oshimura M; Usui T
    Biopharm Drug Dispos; 2016 Jan; 37(1):3-14. PubMed ID: 26352195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of human metabolism of FK3453 by aldehyde oxidase using chimeric mice transplanted with human or rat hepatocytes.
    Sanoh S; Nozaki K; Murai H; Terashita S; Teramura T; Ohta S
    Drug Metab Dispos; 2012 Jan; 40(1):76-82. PubMed ID: 21984595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologically Based Pharmacokinetic Modeling for Quantitative Prediction of Exposure to a Human Disproportionate Metabolite of the Selective Na
    Asano D; Nakamura K; Nishiya Y; Shiozawa H; Takakusa H; Shibayama T; Inoue SI; Shinozuka T; Hamada T; Yahara C; Watanabe N; Yoshinari K
    Drug Metab Dispos; 2023 Jan; 51(1):67-80. PubMed ID: 36273823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictability of metabolism of ibuprofen and naproxen using chimeric mice with human hepatocytes.
    Sanoh S; Horiguchi A; Sugihara K; Kotake Y; Tayama Y; Uramaru N; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S
    Drug Metab Dispos; 2012 Dec; 40(12):2267-72. PubMed ID: 22936315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant species difference in amide hydrolysis of GDC-0834, a novel potent and selective Bruton's tyrosine kinase inhibitor.
    Liu L; Halladay JS; Shin Y; Wong S; Coraggio M; La H; Baumgardner M; Le H; Gopaul S; Boggs J; Kuebler P; Davis JC; Liao XC; Lubach JW; Deese A; Sowell CG; Currie KS; Young WB; Khojasteh SC; Hop CE; Wong H
    Drug Metab Dispos; 2011 Oct; 39(10):1840-9. PubMed ID: 21742900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
    Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ
    Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of human metabolism of the sedative-hypnotic zaleplon using chimeric mice transplanted with human hepatocytes.
    Tanoue C; Sugihara K; Uramaru N; Tayama Y; Watanabe Y; Horie T; Ohta S; Kitamura S
    Xenobiotica; 2013 Nov; 43(11):956-62. PubMed ID: 23651075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Aldehyde Oxidase 1-Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes.
    Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
    Drug Metab Dispos; 2020 Jul; 48(7):580-586. PubMed ID: 32357972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous and xenobiotic metabolite profiling of liver extracts from SCID and chimeric humanized mice following repeated oral administration of troglitazone.
    Barnes AJ; Baker DR; Hobby K; Ashton S; Michopoulos F; Spagou K; Loftus NJ; Wilson ID
    Xenobiotica; 2014 Jan; 44(2):174-85. PubMed ID: 24350779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of in vivo hepatic clearance and half-life of drug candidates in human using chimeric mice with humanized liver.
    Sanoh S; Horiguchi A; Sugihara K; Kotake Y; Tayama Y; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S
    Drug Metab Dispos; 2012 Feb; 40(2):322-8. PubMed ID: 22048522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Human Disproportionate and Biliary Excreted Metabolites Using Chimeric Mice with Humanized Liver.
    Kato S; Shah A; Plesescu M; Miyata Y; Bolleddula J; Chowdhury S; Zhu X
    Drug Metab Dispos; 2020 Oct; 48(10):934-943. PubMed ID: 32665417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
    Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
    Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Characterization of YM543, a Newly Synthesized, Orally Active SGLT2 Selective Inhibitor.
    Yokono M; Tahara A; Kurosaki E; Yamajuku D; Kihara R; Imamura M; Tomiyama H; Kobayashi Y; Noda A; Shibasaki M
    Endocr Res; 2013 Aug; 38(3):168-183. PubMed ID: 23374077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of the accumulative human metabolite and human-specific glutathione conjugate of diclofenac in TK-NOG chimeric mice with humanized livers.
    Kamimura H; Ito S; Nozawa K; Nakamura S; Chijiwa H; Nagatsuka S; Kuronuma M; Ohnishi Y; Suemizu H; Ninomiya S
    Drug Metab Dispos; 2015 Mar; 43(3):309-16. PubMed ID: 25504502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric mice with humanized liver.
    Katoh M; Tateno C; Yoshizato K; Yokoi T
    Toxicology; 2008 Apr; 246(1):9-17. PubMed ID: 18248870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excretion, metabolism, and pharmacokinetics of CP-945,598, a selective cannabinoid receptor antagonist, in rats, mice, and dogs.
    Miao Z; Scott DO; Griffith DA; Day R; Prakash C
    Drug Metab Dispos; 2011 Dec; 39(12):2191-208. PubMed ID: 21875952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro profiling of the metabolism and drug-drug interaction of tofogliflozin, a potent and highly specific sodium-glucose co-transporter 2 inhibitor, using human liver microsomes, human hepatocytes, and recombinant human CYP.
    Yamane M; Kawashima K; Yamaguchi K; Nagao S; Sato M; Suzuki M; Honda K; Hagita H; Kuhlmann O; Poirier A; Fowler S; Funk C; Simon S; Aso Y; Ikeda S; Ishigai M
    Xenobiotica; 2015 Mar; 45(3):230-8. PubMed ID: 25350082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the pharmacokinetics, biotransformation and hepatic transporter effects of troglitazone in mice with humanized livers.
    Schulz-Utermoehl T; Sarda S; Foster JR; Jacobsen M; Kenna JG; Morikawa Y; Salmu J; Gross G; Wilson ID
    Xenobiotica; 2012 Jun; 42(6):503-17. PubMed ID: 22201515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.